BioNTech (BNTX) PT Lowered to $101 at UBS
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $92.12 --0%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 9
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 9
Join SI Premium – FREE
UBS analyst Andrew Ang lowered the price target on BioNTech (NASDAQ: BNTX) to $101.00 (from $110.00) while maintaining a Neutral rating.
You May Also Be Interested In
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
- Vinati Organics Ltd (VO:IN) PT Lowered to INR1,170 at Kotak
- Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
